AGTC Abuzz, AMRN Slumps & CORT Soars As Oral Arguments Commence, FLGT Gears Up, NNVC On Watch
Todays Daily Dose brings you news about Applied Genetics upcoming presentation, oral arguments in patent suits of Amarin and Corcept,…
Börse:
1,431$
0,05%
Echtzeit-Aktienkurs Amarin Corp. PLC (Spons. ADRs)
Bid:
1,412$
Ask:
1,450$
Nachrichten zur Amarin Corp. PLC (Spons. ADRs) Aktie
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 2, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces…
Why Amarin Stock Is Getting Slammed Today
An appeal hearing for Vascepas patent case isnt sitting well with investors....…
Amarin Shares Off - Analysts Mull Prospects of Patent-Case Appeal
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why Amarin Shares Are Plunging Wednesday
Amarin Corporation plc (NASDAQ: AMRN) shares were plummeting on above-average volume as an appeal hearing on the Vascepa fish oil…
Amarin Plummets After Patent Appeal Shows Key Drug Sales at Risk
Amarin Plummets After Patent Appeal Shows Key Drug Sales at Risk...…
Thinking about buying stock in Advanced Micro Devices, Lonestar Resources, Amarin Corp, SmileDirectClub, or Vera Bradley?
NEW YORK , Sept. 2, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMD,…
Amarin under pressure on advancement of Vascepa patent case
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Corporation: Bullish Financials Point To A Higher Share Price
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Supports Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Persistent Cardiovascular Risk Presented at ESC Congress 2020, the Annual Meeting of the European Society of Cardiology
VASCEPA is the first and only agent studied on top of statin therapy reported to exhibit coronary plaque regression in…
Amarin Patent Appeal Is a Coin Toss With Billions on the Line
Amarin Patent Appeal Is a Coin Toss With Billions on the Line...…
Thinking about buying stock in Aimmune Therapeutics, FSD Pharma, Amarin Corp, Trevena Inc, or American Airlines?
NEW YORK , Aug. 31, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AIMT,…
The Week Ahead In Biotech: Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing
Biotech stocks went about a consolidation move in the week ended Aug. 28 amid thin news flow. Barring updates on coronavirus…
The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing
Biotech stocks went about a consolidation move in the week ended Aug. 28 amid thin news flow. Barring updates on coronavirus…
VBI Vaccines and Amarin among healthcare gainers; Quidel leads the losers
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin (AMRN) in Focus: Stock Moves 5.5% Higher
Amarin (AMRN) saw a big move last session, as its shares jumped more than 5% on the day, amid huge…
Amarin Corp.: Whether Vascepa Is A COVID-19 Play
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Supports Investigator-Initiated Trial at Kaiser Permanente in the U.S. to Study the Effects of VASCEPA® (icosapent ethyl) in Reducing Viral Upper Respiratory Infections, Including COVID-19 and Flu, and the Clinical Severity of Such Infections
DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today announced support for…
Amarin Earnings, And Other News: The Good, Bad And Ugly Of Biopharma
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin (AMRN) Beats on Q2 Earnings, Focuses on Europe
Amarins (AMRN) revenue growth in the second quarter is attributable to continued demand for its cardiovascular drug, Vascepa....…
4 Reasons Amarin Stock Could Tumble Even Further
The companys second-quarter earnings report was less than encouraging....…
Amarin (AMRN) Q2 2020 Earnings Call Transcript
AMRN earnings call for the period ending June 30, 2020....…
Amarin Reports Mixed Q2 As COVID-19 Weighs On Results; Analyst Sees Favorable Risk-Reward
Amarin Corporation plc (NASDAQ: AMRN) shares were advancing strongly Tuesday following the release Tuesday of second-quarter results.
Latest Ratings…
Amarin Announces Plans to Maximize Blockbuster Potential of VASCEPA® (icosapent ethyl) in Europe
Amarin to Build Dedicated Organization to Retain Substantial Value of One of the Most Anticipated Cardiovascular Drug Products in Decades...…
Amarin Corporation plc 2020 Q2 - Results - Earnings Call Presentation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin slips 3% on Q2 results; top line +34% despite COVID-19 headwinds
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AMARIN CORP PLCUK: 8-K Report
8-K...…
AMARIN CORP PLCUK: 10-Q Report
10-Q...…
Amarin EPS beats by $0.11, misses on revenue
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Reports Second Quarter 2020 Financial Results and Provides Update on Operations
Total Revenue Increased 34% in Second Quarter 2020 Compared to Second Quarter 2019 Despite COVID-19 Headwinds...…
Amarin Q2 2020 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The Only Play On Amarin
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin up 3% on new Vascepa data from Reduce-It study
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin to Report Second Quarter 2020 Results and Host Conference Call on August 4, 2020
DUBLIN, Ireland and BRIDGEWATER, N.J., July 21, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that…
AMARIN CORP PLCUK: 8-K Report
8-K...…
Amarin (AMRN) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Amarin (AMRN) closed at $7.03, marking a +1.59% move from the previous day....…
Implied Volatility Surging for Amarin (AMRN) Stock Options
Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately....…
Amarin (AMRN) Gains But Lags Market: What You Should Know
In the latest trading session, Amarin (AMRN) closed at $6.92, marking a +0.58% move from the previous day....…
Amarin (AMRN) Outpaces Stock Market Gains: What You Should Know
Amarin (AMRN) closed at $6.78 in the latest trading session, marking a +0.89% move from the prior day....…
AMARIN CORP PLCUK: 8-K Report
8-K...…
AMRN Makes Peace With Apotex, IDYA Cuts Deal With GSK, SLRX On Watch, NBIX, TAK Ink $2Bln Pact
Todays Daily Dose brings you news about Amarins settlement agreement with Apotex; Annovis Bios progress in its Alzheimers drug development…
Amarin settles with Apotex, delays generic Vascepa until 2029
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Announces Patent Litigation Settlement Agreement with Apotex Inc.
DUBLIN, Ireland and BRIDGEWATER, N.J., June 16, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) announced today a…
Why Some Analysts Remain Bullish on Amarin Stock
Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin (AMRN) Stock Sinks As Market Gains: What You Should Know
Amarin (AMRN) closed the most recent trading day at $6.59, moving -1.35% from the previous trading session....…
Why Amarin (AMRN) Stock Might be a Great Pick
Amarin (AMRN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as…
What Amarin Stock Investors Will Hear at the Annual Meeting
Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin (AMRN) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Amarin (AMRN) closed at $6.68, marking a -1.18% move from the previous day....…
Amarin Stock in a Holding Pattern
Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Will New Marketing Push Pump Amarin Stock?
Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…